By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ariad Pharmaceuticals, Inc. 

26 Landsdowne Street

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-494-0400 Fax: 617-494-8144


ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult-to-treat cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines. For additional information, visit or follow ARIAD on Twitter (@ARIADPharm).

Key Statistics

Ownership: Public

Web Site: Ariad
Symbol: ARIA

Company News
Ariad (ARIA) Names Former Bristol-Myers Squibb (BMY) Exec as Chief Commercial Officer 5/25/2016 6:11:52 AM
Ariad (ARIA) Announces Appointment Of Jennifer L. Herron As Chief Commercial Officer 5/24/2016 11:21:39 AM
Ariad (ARIA) Announces Data Presentations At The 2016 ASCO Annual Meeting 5/19/2016 11:54:39 AM
Ariad (ARIA) Announces Pricing And Reimbursement For Iclusig In France 5/19/2016 9:35:32 AM
Ariad (ARIA) Reports First Quarter 2016 Financial Results And Progress On Strategic Review 5/10/2016 12:32:26 PM
Incyte (INCY) Buys Ariad (ARIA)'s EU Operations and Iclusig Rights for $140 Million Upfront 5/9/2016 6:06:54 AM
Ariad (ARIA) To Webcast Conference Call On First Quarter 2016 Financial Results 4/26/2016 12:08:07 PM
Ariad (ARIA) Announces Results Of Preclinical Studies On AP32788 At The Annual Meeting Of AACR 4/19/2016 11:37:14 AM
Ariad (ARIA) Presents Updated Phase 1/2 Clinical Data On Brigatinib In Patients With ALK+ Non-Small Cell Lung Cancer 4/15/2016 9:29:01 AM
Struggling Ariad (ARIA)'s Luck Might be Turning Around as Company Eyes Pfizer (PFE)'s ALK Space 4/12/2016 8:41:40 AM